Effects of Yinhuang buccal tablets on the microecology of upper respiratory tract and intestinal metabolites in healthy people

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000029633

Enrollment

Unknown

Registered

2020-02-08

Start date

2020-03-01

Completion date

Unknown

Last updated

2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

control group: taking yinhuang buccal tablets placebo

experimental group:taking yinhuang buccal tablets

Eligibility

Sex/Gender

All

Age

18 Years to 39 Years

Inclusion criteria

Inclusion criteria: (1) aged >= 18, <= 39 years; (2) the subject has no history of chronic or serious diseases of cardiovascular, liver, kidney, respiratory, blood and lymph, endocrine, immune, mental, nervous and gastrointestinal systems; (3) the subject is informed and agrees to sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) antiviral or antibiotic drugs should be used within the past two months; (2) a history of respiratory tract infection in the past 1 month; (3) redness or ulceration of oral and pharyngeal mucosa; (4) pregnancy or lactation, smoking history, history of alcohol abuse, history of allergy to traditional Chinese medicine; (5) mentally ill patients, others unable or unwilling to cooperate; (6) other participants in the past 3 months.(7)Spleen and stomach cold deficiency.

Design outcomes

Primary

Measure	Time frame
Potential pathogens of the upper respiratory tract;Dominant bacteria in the upper respiratory tract;	—

Secondary

Measure	Time frame
Microecological biodiversity of upper respiratory tract;Biomarkers of intestinal metabolites;	—

Countries

China

Contacts

Public ContactLiu Qingquan

Beijing Hospital of Traditional Chinese Medicine

liuqingquan2003@126.com+86 13910055687

Outcome results